Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 2/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL27831534 | 0.97 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL27826318 | 0.97 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL27519299 | 0.91 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL574925 | 0.89 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL27964313 | 0.86 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL9460589 | 0.86 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL2290380 | 0.86 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL28243370 | 0.86 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL18529183 | 0.86 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1CA1CA2CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL39465 | 0.86 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114540848-B | Decarboxylation coupling electrocatalytic method for realizing catalysis of aromatic trimethylammonium salt and alpha-nickel ketoacid | 常州工学院 | 2023-09-01 | — | — | CN | claimed |
| CN-116650700-A | Chitosan copolymer hemostatic dressing and preparation method thereof | 湖南玉津医疗科技有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-114617983-B | Fluorine-18 labeled CEA molecular targeting compound and preparation method and application thereof | 中山大学附属第五医院 | 2022-08-09 | — | — | CN | claimed |
| CN-114617983-A | Fluorine-18 labeled CEA molecular targeting compound and preparation method and application thereof | 中山大学附属第五医院 | 2022-06-14 | — | — | CN | claimed |
| CN-111393253-A | Synthesis method of compound containing trans-substituted cyclohexyl | 江苏广域化学有限公司 | 2020-07-10 | — | — | CN | claimed |
| CN-105330824-A | Flame retardant curing agent for epoxy resin and preparation method of flame retardant curing agent | XI AN ORIGIN CHEMICAL TECHNOLOGIES CO LTD | 2016-02-17 | — | — | CN | claimed |
| CN-103951681-B | Prepare thiazole also [3,2-a] pyridine derivatives that is antitumor and apoptosis related disease | ZUNYI MEDICAL COLLEGE (CN) | 2016-02-10 | — | — | CN | claimed |
| CN-104650162-A | Preparation method of kinsenoside | PARLING SHANGHAI PHARMATECH CO LTD | 2015-05-27 | — | — | CN | claimed |
| CN-104370982-A | Diphyllin derivatives, and preparation method and application thereof | UNIV NANKAI | 2015-02-25 | — | — | CN | claimed |
| CN-104124463-A | Ionic liquid-polymer composite membrane for hydrogen chloride fuel cell and preparation and application thereof | DALIAN CHEMICAL PHYSICS INST | 2014-10-29 | — | — | CN | claimed |
| CN-102875613-B | Hexadecanol glucose dimeric surfactant and preparation method thereof | UNIV ZHEJIANG | 2014-04-16 | — | — | CN | claimed |
| EP-1658268-B1 | MIXTURES OF IONIC LIQUIDS WITH LEWIS ACIDS | NOVARTIS AG (CH) | 2014-02-12 | — | — | EP | claimed |
| CN-102875613-A | Hexadecanol glucose dimeric surfactant and preparation method thereof | UNIV ZHEJIANG | 2013-01-16 | — | — | CN | claimed |
| CN-102876759-A | Preparation method of nicotinamide adenine dinucleotide | SYCOZYMES SHANGHAI CO LTD | 2013-01-16 | — | — | CN | claimed |
| CN-102282155-A | Method for the synthesis of phosphorus atom modified nucleic acids | — | 2011-12-14 | — | — | CN | claimed |
| CN-101974067-A | Solasodine-3-O-alpha-L-rhamnoside as well as preparation method and application thereof | UNIV SHANDONG | 2011-02-16 | — | — | CN | claimed |
| US-7456202-B2 | Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-11-25 | — | — | US | claimed |
| US-20050249662-A1 | Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules | COMMISSARIAT A L'ENERGIE (FR) | 2005-11-10 | — | — | US | claimed |
| EP-1517903-A2 | MARKED MALEIMIDE COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR MARKING MACROMOLECULES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2005-03-30 | — | — | EP | claimed |
| WO-2004002984-A2 | MARKED MALEIMIDE COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR MARKING MACROMOLECULES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2004-01-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050249662-A1 | Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules | CRBN, NR2E3, NR2C2 | ALDH1A1 2157/4885L3MBTL1 4729/4885CA1 470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.